NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
8 hedge funds and large institutions have $515K invested in NeuroMetrix, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
39% more capital invested
Capital invested by funds: $371K → $515K (+$144K)
14% more funds holding
Funds holding: 7 → 8 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$193K |
| 2 |
Renaissance Technologies
New York
|
+$75.6K |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$58.8K |
| 4 |
OFS
Orrstown Financial Services
Harrisburg,
Pennsylvania
|
+$19.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$988 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$43K |
| 2 |
Morgan Stanley
New York
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $190K | +$193K | +1,170 | New |
|
|
2
Renaissance Technologies
New York
| $150K | +$75.6K | +459 | +100% |
|
3
Bank of New York Mellon
New York
| $58K | – | – | – |
|
|
4
Macquarie Group
Sydney, NSW 2000,
Australia
| $58K | +$58.8K | +357 | New |
|
5
BlackRock
New York
| $31K | – | – | – |
|
|
OFS
6
Orrstown Financial Services
Harrisburg,
Pennsylvania
| $19K | +$19.6K | +119 | New |
|
7
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $8K | +$823 | +5 | +11% |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | +$988 | +6 | New |
|
|
9
Goldman Sachs
New York
| – | -$43K | -201 | Closed |
|
|
10
Morgan Stanley
New York
| – | -$31K | -146 | Closed |
|
NURO Hedge Fund Activity: Q3 2017 in Review
8 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q3 2017, worth a combined $515K — up 39% from $371K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NURO positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $193K. The largest seller was Goldman Sachs, exiting entirely with an estimated $43K sold.
- 8 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q3 2017, up from 7 in Q2 2017.
- Funds reported $515K of NeuroMetrix, Inc. Common Stock stock for Q3 2017, up 39% quarter-over-quarter.
- 4 funds opened new NeuroMetrix, Inc. Common Stock positions in Q3 2017 and 2 closed out, a net change of +2 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q3 2017 was Sabby Management, an estimated $193K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q3 2017 was Goldman Sachs, an estimated $43K sold.
Based on aggregated 13F filings for Q3 2017.